XML 65 R37.htm IDEA: XBRL DOCUMENT v3.25.0.1

Net Loss Per Share Allocable to Common Stockholders (Tables)

12 Months Ended

Dec. 31, 2024

Earnings Per Share [Abstract]

Schedule of Computation of Basic and Diluted Net Loss Per Share Allocable to Common Stockholders

The following table sets forth the computation of basic and diluted net loss per share allocable to common stockholders (in thousands, except share and per-share data):

												Year Ended December 31,
																								2024						2023
Numerator:
Net loss																								$	(77,424)					$	(219,710)
Less: CVR distribution to participating securities																								—						(37,550)
Net loss allocable to shares of common stock - basic																								(77,424)						(257,260)
Less: Change in fair value of forward contract liability settled in February 2024																								(446)						—
Net loss allocable to shares of common stock - diluted																								$	(77,870)					$	(257,260)
Denominator:
Weighted-average common shares outstanding - basic																								17,276,822						5,170,319
Plus: Dilutive effect of forward contract liability settled in February 2024																								81,121						—
Weighted-average common shares outstanding - diluted																								17,357,943						5,170,319
Net loss per share:
Basic																								$	(4.48)					$	(49.76)
Diluted																								$	(4.49)					$	(49.76)

Schedule of Potential Dilutive Shares of Common Stock Excluded from the Computation of the Diluted Net Loss Per Share Allocable to Common Stockholders

The following table represents the potential dilutive shares of common stock excluded from the computation of the diluted net loss per share allocable to common stockholders for all periods presented, as the effect would have been anti-dilutive:

			Year Ended December 31,
			2024						2023
Common stock options and RSUs			2,150,273						776,865
Warrants to purchase common stock			692,523						1,040,813
Series A Preferred Stock			4,026,346						14,503,993
Series B Preferred Stock			437,927						—
Forward contract to issue Series A Preferred Stock			—						3,304,677
Series A Preferred Stock options			—						470,403
Total			7,307,069						20,096,751

X

- References

No definition available.

+ Details

Name:	us-gaap_EarningsPerShareAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration